Effect of Human Plasma on Hepatic Uptake of Organic Anion–Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes-Reference-Cited by-同舟云学术

Effect of Human Plasma on Hepatic Uptake of Organic Anion–Transporting Polypeptide 1B Substrates: Studies Using Transfected Cells and Primary Human Hepatocytes

Published:2020-11-02 Issue:1 Volume:49 Page:72-83
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Bi Yi-an,Ryu Sangwoo,Tess David A.,Rodrigues A. David,Varma Manthena V. S.^ORCID

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference63 articles.

1. Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far?;Alluri;Expert Opin Drug Metab Toxicol,2020

2. Baik J Huang Y (2015) Transporter-induced protein binding shift (TIPBS) hypothesis and modeling, in 20th North American ISSX Meeting; Orlando, FL.

3. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile;Balani;Drug Metab Dispos,1997

4. Effect of hepatic organic anion-transporting polypeptide 1B inhibition and chronic kidney disease on the pharmacokinetics of a liver-targeted glucokinase activator: a model-based evaluation;Bergman;Clin Pharmacol Ther,2019

5. Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug transporters in drug disposition – highlights from the year 2023;Drug Metabolism Reviews;2024-09-11

2. An Overview of Interpretability of Two Models of Unbound Fraction that are Used in Combination with the Well-Stirred Model for Predicting Hepatic Clearance of Drugs;Journal of Pharmaceutical Sciences;2024-09

3. Albumin-Mediated Drug Uptake by Organic Anion Transporter 1/3 Is Real: Implications for the Prediction of Active Renal Secretion Clearance;Molecular Pharmaceutics;2024-08-21

4. Physiologically Based Pharmacokinetic Model of OATP1B Substrates with a Nonlinear Mixed Effect Approach: Estimating Empirical In Vitro-to-In Vivo Scaling Factors;Clinical Pharmacokinetics;2024-08

5. Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target‐mediated drug disposition and OATP1B3‐mediated hepatic uptake in a physiologically based model;CPT: Pharmacometrics & Systems Pharmacology;2024-05-14